520 related articles for article (PubMed ID: 31317555)
1. Circular RNA hsa_circRNA_103809 promoted hepatocellular carcinoma development by regulating miR-377-3p/FGFR1/ERK axis.
Zhan W; Liao X; Chen Z; Li L; Tian T; Yu L; Wang W; Hu Q
J Cell Physiol; 2020 Feb; 235(2):1733-1745. PubMed ID: 31317555
[TBL] [Abstract][Full Text] [Related]
2. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
[TBL] [Abstract][Full Text] [Related]
3. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
Liu G; Guo W; Rao M; Qin J; Hu F; Li K
Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
[TBL] [Abstract][Full Text] [Related]
4. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
5. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis.
Gong J; Du C; Sun N; Xiao X; Wu H
J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904
[TBL] [Abstract][Full Text] [Related]
6. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307.
Wang YG; Wang T; Ding M; Xiang SH; Shi M; Zhai B
Cancer Lett; 2019 Sep; 460():128-138. PubMed ID: 31207319
[TBL] [Abstract][Full Text] [Related]
7. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA hsa_circ_0056836 functions an oncogenic gene in hepatocellular carcinoma through modulating miR-766-3p/FOSL2 axis.
Li Z; Liu Y; Yan J; Zeng Q; Hu Y; Wang H; Li H; Li J; Yu Z
Aging (Albany NY); 2020 Feb; 12(3):2485-2497. PubMed ID: 32048611
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinoma.
Yang J; Li Y; Yu Z; Zhou Y; Tu J; Lou J; Wang Y
Mol Med Rep; 2020 Jun; 21(6):2395-2404. PubMed ID: 32323783
[TBL] [Abstract][Full Text] [Related]
10. Effects of hsa_circ_0000711 expression level on proliferation and apoptosis of hepatoma cells.
Chen KH; Pan JF; Chen ZX; Pan D; Gao T; Huang M; Huang JN
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4161-4171. PubMed ID: 32373952
[TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
12. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
Jin J; Liu H; Jin M; Li W; Xu H; Wei F
Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
[TBL] [Abstract][Full Text] [Related]
13. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
Wang F; Ying HQ; He BS; Pan YQ; Deng QW; Sun HL; Chen J; Liu X; Wang SK
Oncotarget; 2015 Apr; 6(10):7899-917. PubMed ID: 25760077
[TBL] [Abstract][Full Text] [Related]
14. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
[TBL] [Abstract][Full Text] [Related]
16. hsa_circ_0006916 promotes hepatocellular carcinoma progression by activating the miR-337-3p/STAT3 axis.
Zhou XY; Yang H; Bai YQ; Li XL; Han SY; Zhou BX
Cell Mol Biol Lett; 2020 Nov; 25(1):47. PubMed ID: 33292166
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA hsa_circ_0000673 promotes hepatocellular carcinoma malignance by decreasing miR-767-3p targeting SET.
Jiang W; Wen D; Gong L; Wang Y; Liu Z; Yin F
Biochem Biophys Res Commun; 2018 Jun; 500(2):211-216. PubMed ID: 29627570
[TBL] [Abstract][Full Text] [Related]
18. Piplartine attenuates the proliferation of hepatocellular carcinoma cells via regulating hsa_circ_100338 expression.
Cheng X; Tian P; Zheng W; Yan X
Cancer Med; 2020 Jun; 9(12):4265-4273. PubMed ID: 32281302
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA hsa_circ_103809 suppresses hepatocellular carcinoma proliferation and invasion by sponging miR-620.
Li X; Shen M
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(2):555-566. PubMed ID: 30720163
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.
Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]